{"id":"W4399519774","doi":"10.1200/jco.2024.42.16_suppl.6509","title":"Preliminary safety and efficacy of oral azacitidine (Oral-AZA) in patients (pts) with low-/Intermediate (Int)-risk myelodysplastic syndromes (MDS): Phase 2 results from the ASTREON trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Azacitidine; Myelodysplastic syndromes; Internal medicine; Oncology; INT; Clinical trial; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002208121,0.0008318892,0.001437549,0.000278379,0.0003205005,0.0008856138,0.0005966892,0.001092193,0.003893176],"category_scores_gemma":[0.001358622,0.0002975148,0.001254777,0.0003466711,0.0006441115,0.0006856132,0.0003478311,0.002293227,0.000768279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005718054,"about_ca_system_score_gemma":0.001092081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005825773,"about_ca_topic_score_gemma":0.003019465,"domain_scores_codex":[0.9992668,0.0004979727,0.00004782961,0.00007387451,0.00005990933,0.0000535655],"domain_scores_gemma":[0.9989503,0.0002988105,0.0003136384,0.00008252526,0.00007870914,0.0002760666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.827318,0.01855886,0.01916553,0.001563867,0.002763066,0.0003315285,0.0003329325,0.002071072,0.02572364,0.0002848994,0.008557661,0.093329],"study_design_scores_gemma":[0.5538743,0.3896834,0.03896157,0.0001531004,0.002741076,0.0006661158,0.0001129411,0.001445297,0.004109534,0.0004633528,0.007732728,0.00005672923],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872609,0.004841816,0.0003342358,0.0007271379,0.0000788903,0.001143694,0.002204576,0.00006860549,0.003340238],"genre_scores_gemma":[0.9854853,0.002768009,0.00145145,0.001285104,0.000158987,0.001319372,0.005223127,0.0000320732,0.002276757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003893176,"threshold_uncertainty_score":0.01302391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05662040660429468,"score_gpt":0.420154701999125,"score_spread":0.3635342953948303,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}